SHEIBAN, Imad
 Distribuzione geografica
Continente #
NA - Nord America 5.134
AS - Asia 2.686
EU - Europa 2.517
SA - Sud America 412
Continente sconosciuto - Info sul continente non disponibili 272
AF - Africa 46
OC - Oceania 7
Totale 11.074
Nazione #
US - Stati Uniti d'America 4.953
SG - Singapore 1.111
CN - Cina 759
IT - Italia 737
IE - Irlanda 318
BR - Brasile 302
VN - Vietnam 298
SE - Svezia 286
FR - Francia 238
FI - Finlandia 199
DE - Germania 197
UA - Ucraina 165
KR - Corea 154
AT - Austria 112
CA - Canada 106
GB - Regno Unito 78
PL - Polonia 75
IN - India 74
HK - Hong Kong 69
JP - Giappone 53
AR - Argentina 44
BD - Bangladesh 30
NL - Olanda 25
ID - Indonesia 22
IQ - Iraq 22
CL - Cile 20
RU - Federazione Russa 17
ZA - Sudafrica 16
MX - Messico 15
BE - Belgio 13
TR - Turchia 13
VE - Venezuela 13
EC - Ecuador 12
CO - Colombia 11
JM - Giamaica 11
UZ - Uzbekistan 10
PH - Filippine 9
PK - Pakistan 9
TH - Thailandia 7
BG - Bulgaria 6
ES - Italia 6
GR - Grecia 6
NI - Nicaragua 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
DK - Danimarca 5
HR - Croazia 5
JO - Giordania 5
MA - Marocco 5
TN - Tunisia 5
AU - Australia 4
BB - Barbados 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
EE - Estonia 4
IL - Israele 4
KG - Kirghizistan 4
LT - Lituania 4
MU - Mauritius 4
NO - Norvegia 4
PA - Panama 4
PR - Porto Rico 4
TW - Taiwan 4
AL - Albania 3
BS - Bahamas 3
CH - Svizzera 3
EU - Europa 3
GT - Guatemala 3
HN - Honduras 3
MY - Malesia 3
PE - Perù 3
PY - Paraguay 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
BZ - Belize 2
CI - Costa d'Avorio 2
DZ - Algeria 2
HU - Ungheria 2
KE - Kenya 2
KH - Cambogia 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
CV - Capo Verde 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ET - Etiopia 1
Totale 10.786
Città #
Singapore 657
Beijing 478
Chandler 427
Santa Clara 398
Ashburn 396
San Jose 360
Dublin 316
Houston 168
Ann Arbor 154
Milan 136
Torino 120
Medford 111
Vienna 103
Jacksonville 102
Princeton 98
Fairfield 94
Council Bluffs 93
Columbus 84
Lauterbourg 84
The Dalles 84
Wilmington 84
Los Angeles 82
Villeurbanne 81
Buffalo 80
Dearborn 80
Nyköping 79
Rome 78
Ho Chi Minh City 73
Warsaw 70
Hong Kong 62
New York 59
Hanoi 58
Dallas 57
Fremont 47
Seattle 41
Toronto 37
Tokyo 32
Pavia 31
Munich 29
Woodbridge 29
Boston 28
Cambridge 27
Helsinki 27
Redwood City 27
Dong Ket 26
Turin 25
Hefei 23
Düsseldorf 22
São Paulo 22
Chicago 21
Atlanta 18
Boardman 18
Figino 18
Guangzhou 18
Montreal 18
Naples 18
Shanghai 18
Haiphong 17
Nuremberg 17
Santiago 17
Da Nang 16
Pisa 16
Seoul 16
Falls Church 15
Nanjing 15
Norwalk 14
Redondo Beach 14
Washington 14
Amsterdam 13
Brussels 13
Duncan 13
Orem 13
Brasília 12
Brooklyn 12
Florence 12
Detroit 11
Jakarta 11
Paris 11
Phoenix 11
Frankfurt am Main 10
Johannesburg 10
Las Vegas 10
Philadelphia 10
Queens 10
Turku 10
Jinan 9
Kunming 9
Palermo 9
Baghdad 8
Bologna 8
Chennai 8
Miami 8
Stockholm 8
Verona 8
Catania 7
Denver 7
Hải Dương 7
London 7
Memphis 7
Salvador 7
Totale 6.506
Nome #
30days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: A multicenter study. 278
Safety and efficacy of polymer-free biolimus-eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries 276
Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomes 260
Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteries 254
Intramural left atrial hematoma: A complication of primary coronary angioplasty inferior myocardial infarction 244
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations 214
PPARy in coronary atherosclerosis: In vivo expression pattern and correlations with hyperlipidemic status and statin treatment 210
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) 206
Preclinical evaluation of a novel abluminal surface coated sirolimus eluting stent with biodegradable polymer matrix 205
Homing of Annexin-labeled stem cells to apoptotic cells 168
Impact of multivessel coronary disease on long-term outcome after percutaneous recanalization of coronary chronic total occlusions 160
Diffuse coronary disease: short- and long-term outcome after percutaneous coronary intervention. 156
Comparison of Mortality Rates in Women Versus Men Presenting With ST-Segment Elevation Myocardial Infarction 152
Percutaneous drug-eluting stent implantation in diabetic patients: short and long term outcomes from an observational study. 151
Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations 151
Impact of Kissing Balloon in Patients Treated with Ultrathin Stents for Left Main Lesions and Bifurcations: An Analysis from the RAIN-CARDIOGROUP VII Study 151
Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study) 150
Appraising failure of surgical and percutaneous revascularization: long term outcomes from an observational registry. 147
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life) 145
Impact of TAVI on Mitral Regurgitation: A Prospective Echocardiographic Study 142
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease 139
Long-term (≥10 years) safety of percutaneous treatment of unprotected left main stenosis with drug-eluting stents 139
Percutaneous coronary intervention in nonagenarian: a meta-analysis of observational studies. 137
In vivo coronary plaque histology in patients with stable and acute coronary syndromes. Relationships with hyperlipidemic status and statin treatment 129
Gender differences in patients undergoing TAVI: a multicentre study. 129
Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes. 127
Alterazioni elettrocardiografiche post-TAVI in acuto. 127
Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: evidence from a meta-regression 124
Impact of stent thickness on clinical outcomes in small vessel and bifurcation lesions: a RAIN-CARDIOGROUP VII sub-study 122
Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry. 120
A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions 119
Telecardiogram: still of matter in the modern cardiac imaging era? 117
Unprotected left main coronary disease and ST-segment elevation myocardial infarction: a contemporary review and argument for percutaneous coronary intervention. 117
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial. 116
Percutaneous coronary intervention or coronary artery bypass graft in left main coronary artery disease: a comprehensive meta-analysis of adjusted observational studies and randomized controlled trials 116
Efficacy of a novel anti-inflammatory drug-eluting balloon coated with genistein before stent implantation in porcine coronary arteries 115
Cateterismo cardiaco transettale 115
Analysis of recurrent revascularization events following percutaneous coronary intervention of diabetic patients 114
Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions 114
Clinical and pharmacological management of a high risk diabetic population undergoing percutaneous coronary interventions 113
Safety of coronary collateral stenting in a patient with acute coronary syndrome 111
[Left main coronary artery stenosis]. 110
Antithrombotic strategies following coronary artery stenting in patients on oral anticoagulation for atrial fibrillation 109
Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS). 107
Buddy balloon to deliver a percutaneous aortic valve device: a percutaneous shoehorn? 106
Very long-term follow-up of conservative vs invasive strategies for unstable angina and non-ST Segment Elevation Myocardial Infarction 105
Very long-term follow-up of conservative vs invasive strategies for stable angina 104
Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms 103
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trial 103
Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting. 102
Coronary thrombosis in a patient with leukemic thrombocytosis: which was the best treatment? 101
Idiopathic thrombocytopenic purpura and percutaneous coronary stenting: A dangerous duo? 101
Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology. 100
Impact of acute coronary syndromes on two-year clinical outcomes in patients with unprotected left main coronary artery stenosis treated with drug-eluting stents. 99
Short and long-term outcomes of percutaneous revascularization in patients with prior coronary artery bypass graft. 98
Percutaneous coronary intervention on left main coronary artery trifurcation 97
Volatile anesthetics reduce mortality in cardiac surgery. 97
Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacement. 97
Systematic reviews and meta-analyses "For Dummies". 96
Diagnosis and treatment of patent foramen ovale patency after percutaneous closure 96
Quantitative coronary angiography in the current era: principles and applications. 95
[Left main coronary stenting is safe and effective and is a valuable alternative to coronary artery bypass graft surgery]. 94
Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease 94
Repeat adverse events long after percutaneous coronary revascularization in diabetics 93
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study). 91
Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology. 91
Comparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: results of the GISSOC II-GISE multicentre randomized trial. 90
Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry) 87
Postpartum valve thrombosis: a happy ending thriller. 87
Epidural analgesia improves outcome in cardiac surgery: a meta-analysis of randomized controlled trials. 86
Temporal pattern of ischemic events in relation to dual antiplatelet therapy in patients with unprotected left main coronary artery stenosis undergoing percutaneous coronary intervention. 86
Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study. 85
Letter regarding article by Solomon et al, "Cardiac Angiography inREnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease 85
Systematic review and meta-analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: much ado about nothing? 84
Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study 82
Evolution of conduction disturbances following transcatheter aortic valve implantation over one year follow up 82
Letter by Bollati et al regarding article, "Off-pump versus on-pumpcoronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization" 82
Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry. 81
International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. 81
Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. 81
[Percutaneous transluminal angioplasty: synonymous of quality of life?]. 80
Last nail in the coffin of late lumen loss? 79
Elective implantation of sirolimus-eluting stents for bifurcated and non-bifurcated unprotected left main coronary artery lesions: clinical outcomes at one year. 79
Myocardial viability after primary coronary angioplasty: low-dose dobutamine stress echocardiography versus myocardial contrast echocardiography 79
Management of multivessel coronary disease after ST-elevation myocardial infarction treated by primary coronary angioplasty. 78
Long-term effect of chronic oral anticoagulation: focus on coronary artery disease. 76
Pressure ulcer: an unreported complication of the Safeguard® hemostasis device. No need to crack under pressure. 76
Percutaneous aortic valve replacement in two cases at high surgical risk: procedural details and implications for patient selection. 75
Update on dedicated bifurcation stents. 74
Retrospective multicenter observational study of the interventional management of coronary disease in the very elderly: the NINETY. 71
Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronaryintervention 70
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. 66
Iatrogenic coronary-to-right ventricle fistula: benign outcome irrespective of patency? 62
RAPSTROM™ first-in-man study long-term results of a biodegradable polymer sustained-release sirolimus-eluting stent in de novo coronary stenoses 61
Totale 11.074
Categoria #
all - tutte 37.618
article - articoli 0
book - libri 0
conference - conferenze 2.206
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022683 0 0 0 49 30 33 55 44 19 55 192 206
2022/20231.155 128 76 28 119 115 333 105 59 102 17 59 14
2023/2024531 88 97 32 50 50 54 9 18 9 21 33 70
2024/20251.507 6 179 58 158 320 165 29 53 109 86 114 230
2025/20263.314 321 102 177 391 349 146 478 126 223 241 110 650
2026/2027867 173 313 248 133 0 0 0 0 0 0 0 0
Totale 11.074